Veradace urges Tiptree shareholders to reject Fortegra sale to DB Insurance

Published 13/11/2025, 23:42
Veradace urges Tiptree shareholders to reject Fortegra sale to DB Insurance

DALLAS - Investment firm Veradace Partners, which holds a 5% stake in Tiptree Inc. (NASDAQ:TIPT), has called on shareholders to vote against the proposed sale of The Fortegra Group to DB Insurance Co., Ltd. at the upcoming December 3, 2025, special meeting. Tiptree, currently trading at $19.05 with a market capitalization of $720.35 million, has seen its share price decline by 12.09% over the past six months according to InvestingPro data.

In a presentation released Thursday, Veradace characterized the transaction as "undervalued" and resulting from a "flawed and conflicted process." The investment firm criticized the deal structure as tax-inefficient, claiming it effectively grants management "a $1 billion blank check while delivering no direct return to shareholders." This claim comes despite Tiptree's current P/E ratio of 16.53 and PEG ratio of 0.8, suggesting the stock is trading at a low P/E ratio relative to near-term earnings growth, one of several insights available through InvestingPro's comprehensive analysis.

Veradace raised several concerns about the transaction, including the timing of the sale, which comes months before certain rights held by Warburg Pincus LLC would take effect. The firm also questioned why Tiptree did not retain an investment bank to explore selling the entire company in what it describes as a more tax-efficient manner.

Additionally, Veradace challenged the valuation, arguing the transaction was "priced at a significant discount to comparable companies on a multiple of net income." The firm also questioned why transaction proceeds would not be returned entirely to shareholders.

The investment firm contends there are "numerous superior alternative paths" that could deliver higher returns to Tiptree shareholders and has urged the board to pursue a restructured deal.

Tiptree insiders own approximately 40% of the company's shares, according to Veradace's statement. The special meeting where shareholders will vote on the proposed transaction is scheduled for December 3, 2025.

This article is based on a press release statement from Veradace Partners.

In other recent news, Tiptree Inc. announced plans to divest its insurance business, Fortegra, and a mortgage business in transactions valued at approximately $1.7 billion. The Fortegra sale, priced at $1.65 billion, is expected to bring Tiptree around $1.12 billion in gross proceeds. This deal is currently awaiting regulatory approvals and is projected to close by mid-2026. DB Insurance Co., Ltd. has agreed to acquire Fortegra, marking its largest entry into the U.S. market. However, Veradace Partners L.P., a shareholder with a 5% stake in Tiptree, declared its intention to vote against the sale. Veradace criticized the transaction terms, asserting they favor Tiptree management over shareholders. The firm has called for a restructuring of the deal to ensure direct financial benefits for shareholders. These developments are subject to regulatory and stockholder approvals.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.